Search results
Results from the WOW.Com Content Network
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
With a compound annual growth rate (CAGR) of 9.1%, the global pharmaceuticals industry is projected to expand to $1587.1 billion in 2022 from […] 10 Best Pharma Stocks To Buy Now Skip to main ...
In this article, we will discuss the 10 best pharmaceutical stocks to buy according to billionaire Joseph Edelman. If you want to skip our detailed analysis of Edelman’s history, investment ...
In this article, we discuss the 15 best pharmaceutical stocks to invest in. If you want to skip our detailed analysis of these stocks, go directly to the 5 Best Pharmaceutical Stocks to Invest In.
Valeant Pharmaceuticals: Allergan, Inc: 53.3 69 Valeant raised its unsolicited offer for Allergan a second time, to $53.3 billion, increasing the cash portion of the bid in an effort to win the backing of the company, with the cash-and-stock portion of the bid valuing each Allergan share at $179.25. [26] 16 2014 Valeant Pharmaceuticals ...
Stocks for all the US-publicly traded companies on the list — Bristol-Meyers Squibb , Eli Lilly , Merck , AstraZeneca , Novartis , Amgen , Johnson & Johnson , AbbVie , and Novo Nordisk — were ...